SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
WESCHLER, R. TED

(Last) (First) (Middle)
404 EAST MAIN STREET

(Street)
CHARLOTTESVILLE VA 22902

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA HEALTHCARE PARTNERS INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Member of 10% owner group
3. Date of Earliest Transaction (Month/Day/Year)
11/07/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/07/2014 P 275,501 A $73.3871(2) 37,896,653 I See footnote (1).(1)
Common Stock 11/07/2014 P 530,443 A $74.4534(3) 38,427,096 I See footnote (1).(1)
Common Stock 11/07/2014 P 14,074 A $74.8666(4) 38,441,170 I See footnote (1).(1)
Common Stock 11/10/2014 P 123,200 A $74.1207(5) 38,564,370 I See footnote (1).(1)
Common Stock 11/10/2014 P 1,200 A $74.6663(6) 38,565,570 I See footnote (1).(1)
Common Stock 2,191,806 D
Common Stock 48,000 I See footnotes (7), (10) and (11).(7)(10)(11)
Common Stock 50,000 I See footnotes (8), (10) and (11).(8)(10)(11)
Common Stock 41,370 I See footnotes (9), (10) and (11).(9)(10)(11)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares of the issuer's Common Stock ("Shares") were acquired by certain subsidiaries and subsidiary benefit plans of Berkshire Hathaway Inc. ("Berkshire"). As a result of an agreement entered into on May 24, 2013 between Berkshire and the reporting person with respect to the reporting person's holdings of, and future transactions in, Shares, Berkshire and the reporting person have agreed to file as a "group" under Section 13 of the Securities Exchange Act of 1934, as amended ("the Exchange Act"). The reporting person disclaims beneficial ownership of Shares owned by Berkshire, Berkshire's subsidiaries and its subsidiary pension plans. This report shall not be deemed an admission that the reporting person is the beneficial owner of any Shares that are not directly owned by the reporting person for purposes of Section 16 of the Exchange Act or for any other purpose.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $72.82 to $73.80. The reporting person undertakes to provide to DaVita HealthCare Partners Inc. ("DaVita HCP"), any security holder of DaVita HCP, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2-6 to this Form 4.
3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $73.84 to $74.815.
4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $74.82 to $74.95.
5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $73.63 to $74.61.
6. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $74.63 to $74.95.
7. These shares are owned by a daughter of the reporting person.
8. These shares are owned by the Rita E. Weschler Trust, in which the reporting person may have a remainder interest.
9. These shares are owned by the Rita E. and Frank J. Weschler Educational Trust, of which the reporting person's daughters are beneficiaries.
10. The reporting person has or shares trading authority over these Shares. In addition, the reporting person has or shares trading authority over an aggregate of 52,004 Shares held by certain relatives of the reporting person, but in which the reporting person has no pecuniary interest.
11. The reporting person may be deemed presently to beneficially own, but only to the extent he has a pecuniary interest in, these Shares. The reporting person disclaims beneficial ownership of these Shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 of the Exchange Act or for any other purpose.
/s/ R. Ted Weschler 11/12/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.